Peptide Reports

Melanotan I Peptide Report

Peptide Report

Melanotan I Peptide Report

Catalog report for Melanotan I, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.

All peptide reportsProtocol library
Current Price$49.99 CAD
ProtocolMelanotan I protocol
Catalog SourceBuy Product

Available Options

  • 10 MG

Common Uses

People commonly use Melanotan I in tanning and pigmentation routines, usually when they are looking for gradual skin-tone support alongside careful sun exposure habits.

How It Works

Melanotan I is an alpha-MSH analog that primarily stimulates melanocortin receptors involved in pigmentation, especially MC1R on melanocytes. That receptor signaling increases melanin production in tanning and pigmentation research.

Storage

Powder form: In lyophilized powder form, Melanotan I is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.

Reconstituted: After reconstitution, Melanotan I should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.

Protocol

The full Melanotan I protocol is included below. The standalone protocol page remains available if you want to open it separately.

Open Standalone Protocol

Scope

Preparation examples, syringe conversion, community-reported patterns and important limitations.

Available strengths: 10 MG

Preparation Examples

These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.

Setup Diluent Concentration Unit conversion
10 MG vial – 2 mL example Add 2 mL bacteriostatic water 5 mg/mL Each U-100 unit = 50 mcg
10 MG vial – 1 mL example Add 1 mL bacteriostatic water 10 mg/mL Each U-100 unit = 100 mcg

Syringe Conversion

Reported amount 10 MG setup 10 MG setup
250 mcg 5 units 2.5 units
500 mcg 10 units 5 units
750 mcg 15 units 7.5 units
1 mg 20 units 10 units

Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.

Community-Reported Patterns

Recurring report Frequency seen Context in reports
250 mcg Once daily Lower-start reports
500 mcg Once daily Most recurring range
1 mg Daily in loading discussions Higher experimental use

Observations

  • Community discussions most often centered on tanning and pigmentation goals.
  • The amount, frequency, route and cycle length varied substantially between reports.
  • Reported outcomes were commonly confounded by diet, training, other products or existing treatment.

Caveats

  • Pigment changes and new or changing skin lesions require medical assessment; UV exposure remains carcinogenic.
  • Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.

Sources

  1. Community search: Melanotan I
  2. PubMed literature search: Melanotan I